Hemogenyx (HEMO.L): Positive in vitro data regarding CDX antibodies
30 May 2019
SPA Healthcare - Morning Comment
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SPA Healthcare - Morning Comment
HemoGenyx Pharmaceuticals Plc (HEMO:LON) | 1.6 0 (-3.1%) | Mkt Cap: 22.0m
- Published:
30 May 2019 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Hemogenyx (HEMO.L): Positive in vitro data regarding CDX antibodies